|
EPB41L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.402000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.785820E-01 |
| Normal-vs-Stage2 |
8.320400E-01 |
| Normal-vs-Stage3 |
6.924200E-01 |
| Normal-vs-Stage4 |
1.815590E-02 |
| Stage1-vs-Stage2 |
7.229400E-01 |
| Stage1-vs-Stage3 |
8.283400E-01 |
| Stage1-vs-Stage4 |
3.590100E-02 |
| Stage2-vs-Stage3 |
9.122400E-01 |
| Stage2-vs-Stage4 |
8.152200E-02 |
| Stage3-vs-Stage4 |
4.533700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.799500E-02 |
| Normal-vs-AfricanAmerican |
2.471000E-01 |
| Normal-vs-Asian |
2.426600E-04 |
| Caucasian-vs-AfricanAmerican |
9.561400E-03 |
| Caucasian-vs-Asian |
1.62560000005474E-06 |
| AfricanAmerican-vs-Asian |
9.001800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.208600E-01 |
| Normal-vs-Female |
6.153200E-01 |
| Male-vs-Female |
7.457200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.939400E-01 |
| Normal-vs-Extreme_Weight |
4.910000E-01 |
| Normal-vs-Obese |
2.225800E-01 |
| Normal-vs-Extreme_Obese |
2.164800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.311800E-01 |
| Normal_Weight-vs-Obese |
3.612200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.496200E-01 |
| Extreme_Weight-vs-Obese |
5.733000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.270980E-01 |
| Obese-vs-Extreme_Obese |
6.547500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.947200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.541190E-01 |
| Normal-vs-Age(61-80Yrs) |
5.602800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.034000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.093950E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.559600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.239200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.715200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.080800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.842800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.952200E-02 |
| Normal-VS-Type2 PRCC |
6.711800E-01 |
| Normal-VS-KIRP CIMP |
2.06329999752342E-08 |
| Normal-VS-Unclassified PRCC |
1.456760E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.348600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.4648998921466E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
5.802800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.69340000022444E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
2.750200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.28909999999694E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.895000E-01 |
| Normal-vs-N1 |
2.134600E-01 |
| Normal-vs-N2 |
2.602500E-03 |
| N0-vs-N1 |
3.594400E-01 |
| N0-vs-N2 |
3.318000E-01 |
| N1-vs-N2 |
3.318800E-01 |
|
|
